Is anti-D immunoglobulin still a frontline treatment option for immune thrombocytopenia?

Jenny M. Despotovic, Cindy E. Neunert

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

A 5-year-old boy presents with platelet count of 2×10(9)/L and clinical and laboratory evidence of immune thrombocytopenia. He has epistaxis and oral mucosal bleeding. Complete blood count reveals isolated thrombocytopenia without any decline in hemoglobin and he is Rh+. You are asked if anti-D immunoglobulin is an appropriate initial therapy for this child given the 2010 Food and Drug Administration "black-box" warning.

Original languageEnglish (US)
Pages (from-to)283-285
Number of pages3
JournalHematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program
Volume2013
DOIs
StatePublished - Jan 1 2013

Fingerprint

Drug Labeling
Rho(D) Immune Globulin
Epistaxis
Idiopathic Thrombocytopenic Purpura
Blood Cell Count
United States Food and Drug Administration
Platelet Count
Thrombocytopenia
Hemoglobins
Hemorrhage
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{6b4d9ae70c9146f3a782e044c092a1ce,
title = "Is anti-D immunoglobulin still a frontline treatment option for immune thrombocytopenia?",
abstract = "A 5-year-old boy presents with platelet count of 2×10(9)/L and clinical and laboratory evidence of immune thrombocytopenia. He has epistaxis and oral mucosal bleeding. Complete blood count reveals isolated thrombocytopenia without any decline in hemoglobin and he is Rh+. You are asked if anti-D immunoglobulin is an appropriate initial therapy for this child given the 2010 Food and Drug Administration {"}black-box{"} warning.",
author = "Despotovic, {Jenny M.} and Neunert, {Cindy E.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1182/asheducation-2013.1.283",
language = "English (US)",
volume = "2013",
pages = "283--285",
journal = "Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program",
issn = "1520-4391",
publisher = "American Society of Hematology",

}

TY - JOUR

T1 - Is anti-D immunoglobulin still a frontline treatment option for immune thrombocytopenia?

AU - Despotovic, Jenny M.

AU - Neunert, Cindy E.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - A 5-year-old boy presents with platelet count of 2×10(9)/L and clinical and laboratory evidence of immune thrombocytopenia. He has epistaxis and oral mucosal bleeding. Complete blood count reveals isolated thrombocytopenia without any decline in hemoglobin and he is Rh+. You are asked if anti-D immunoglobulin is an appropriate initial therapy for this child given the 2010 Food and Drug Administration "black-box" warning.

AB - A 5-year-old boy presents with platelet count of 2×10(9)/L and clinical and laboratory evidence of immune thrombocytopenia. He has epistaxis and oral mucosal bleeding. Complete blood count reveals isolated thrombocytopenia without any decline in hemoglobin and he is Rh+. You are asked if anti-D immunoglobulin is an appropriate initial therapy for this child given the 2010 Food and Drug Administration "black-box" warning.

UR - http://www.scopus.com/inward/record.url?scp=84907893995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907893995&partnerID=8YFLogxK

U2 - 10.1182/asheducation-2013.1.283

DO - 10.1182/asheducation-2013.1.283

M3 - Article

C2 - 24319192

AN - SCOPUS:84907893995

VL - 2013

SP - 283

EP - 285

JO - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

JF - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

SN - 1520-4391

ER -